HLB TherapeuticsLtd Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 8.3%.

Top 21 shareholders own 18.43% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
7.46%	HLB Co., Ltd.	5,865,914	₩65.9b	40.3%	no data
3.06%	The Vanguard Group, Inc.	2,403,182	₩27.0b	8.85%	no data
2.79%	HLB GLOBAL Co., Ltd.	2,194,104	₩24.6b	-34.6%	no data
1.42%	HLB Pharmaceutical Co., Ltd.	1,118,192	₩12.6b	0%	no data
1.42%	Epoche Corporation	1,118,192	₩12.6b	0%	no data
0.51%	Dimensional Fund Advisors LP	398,426	₩4.5b	0.16%	no data
0.38%	Norges Bank Investment Management	296,522	₩3.3b	-36.8%	no data
0.28%	HLB Life Science Co., Ltd.	223,638	₩2.5b	0%	no data
0.27%	Mirae Asset Global Investments Co., Ltd.	214,971	₩2.4b	65%	no data
0.23%	Yang-Gon Jin	182,800	₩2.1b	121%	no data
0.17%	BlackRock, Inc.	136,181	₩1.5b	12.1%	no data
0.16%	Charles Schwab Investment Management, Inc.	125,274	₩1.4b	0%	no data
0.1%	Samsung Asset Management Company, Ltd.	79,620	₩894.2m	-50.3%	no data
0.07%	Kihong Ahn	55,051	₩618.2m	0%	no data
0.048%	Epoche Co. Ltd	37,813	₩424.6m	-96.6%	no data
0.037%	State Street Global Advisors, Inc.	29,011	₩325.8m	-12.5%	no data
0.0096%	Hyundai & Cosmos Yachting Co., Ltd.	7,562	₩85.0m	-96.6%	no data
0.0096%	HLB Investment Co., Ltd.	7,562	₩85.0m	-96.6%	no data
0.00057%	NH-Amundi Asset Management	449	₩5.0m	30.1%	no data
0.00052%	Invesco Capital Management LLC	411	₩4.6m	0%	no data
0.00018%	Hanwha Asset Management Co. Ltd.	142	₩1.6m	0%	no data